JP2021512876A5 - - Google Patents
Info
- Publication number
- JP2021512876A5 JP2021512876A5 JP2020542141A JP2020542141A JP2021512876A5 JP 2021512876 A5 JP2021512876 A5 JP 2021512876A5 JP 2020542141 A JP2020542141 A JP 2020542141A JP 2020542141 A JP2020542141 A JP 2020542141A JP 2021512876 A5 JP2021512876 A5 JP 2021512876A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- lipoic
- furoic
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841004306 | 2018-02-05 | ||
| IN201841004306 | 2018-02-05 | ||
| IN201841008091 | 2018-03-05 | ||
| IN201841008091 | 2018-03-05 | ||
| PCT/IB2019/050901 WO2019150341A1 (en) | 2018-02-05 | 2019-02-05 | Combination of an antimuscarinic or an anticholinergic agent and lipoic acid and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021512876A JP2021512876A (ja) | 2021-05-20 |
| JP2021512876A5 true JP2021512876A5 (enExample) | 2022-02-02 |
Family
ID=67480013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542141A Pending JP2021512876A (ja) | 2018-02-05 | 2019-02-05 | 抗ムスカリン薬又は抗コリン作動薬及びリポ酸の組合せ物並びにその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20200375961A1 (enExample) |
| EP (1) | EP3749303A4 (enExample) |
| JP (1) | JP2021512876A (enExample) |
| KR (1) | KR20200118128A (enExample) |
| AU (1) | AU2019214557A1 (enExample) |
| BR (1) | BR112020015436A2 (enExample) |
| CA (1) | CA3089894A1 (enExample) |
| IL (1) | IL276350A (enExample) |
| MX (1) | MX2020008173A (enExample) |
| RU (1) | RU2020122659A (enExample) |
| SG (1) | SG11202006492SA (enExample) |
| WO (1) | WO2019150341A1 (enExample) |
| ZA (1) | ZA202004058B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL265791B (en) * | 2016-10-04 | 2022-07-01 | Cellix Bio Private Ltd | Compositions and methods for the treatment of xerostomia |
| DK3870170T3 (da) | 2018-10-26 | 2026-05-26 | Opus Genetics Inc | Behandling af presbyopi og mydriasis med fentolamin |
| US20220096467A1 (en) * | 2019-01-12 | 2022-03-31 | Cellix Bio Provate Limited | Combination of selective alpha-adrenergic receptor agonist or an anticholinergic agent and lipoic acid and uses thereof |
| CN113387923A (zh) * | 2020-03-13 | 2021-09-14 | 诺华股份有限公司 | 硫辛酸胆碱酯盐的药物组合物及使用其的治疗方法 |
| IL298476A (en) * | 2020-05-26 | 2023-01-01 | Cellix Bio Private Ltd | Pharmaceutical formulations of pilocarpine r-(+)-lipoate |
| WO2022080529A1 (ko) * | 2020-10-15 | 2022-04-21 | 경상대학교병원 | 침분비 저하증 예방 또는 치료용 약학적 조성물 및 건강기능식품 |
| WO2023052977A1 (en) * | 2021-09-29 | 2023-04-06 | Avaca Pharma Private Limited | Compositions, methods and uses thereof |
| WO2023052974A1 (en) * | 2021-09-29 | 2023-04-06 | Avaca Pharma Private Limited | Ocular compositions and methods for the treatment of ophthalmic diseases and disorders |
| CN119454700A (zh) * | 2022-01-18 | 2025-02-18 | 苏州普乐康医药科技有限公司 | 一种含西维美林的眼用制剂及其制备方法和应用 |
| TWI916635B (zh) * | 2022-01-25 | 2026-03-01 | 張金明 | 西維美林水溶液組合物和使用方法 |
| US20250154135A1 (en) * | 2022-01-29 | 2025-05-15 | Nanjing Gritpharma Co., Ltd. | M-choline receptor agonist compound, preparation method therefor and use thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3608073A (en) * | 1968-07-16 | 1971-09-21 | Barnes Hind Pharm Inc | Emulsion of pilocarpine for ophthalmic use |
| US8673964B2 (en) * | 2004-05-20 | 2014-03-18 | Diamedica Inc. | Use of drug combinations for treating insulin resistance |
| US20110150974A1 (en) * | 2004-08-06 | 2011-06-23 | Daiichi Pharmaceutical Co., Ltd. | Agent For Oral Mucosal Administration |
| JP2006070027A (ja) * | 2004-08-06 | 2006-03-16 | Dai Ichi Seiyaku Co Ltd | 口腔粘膜投与剤 |
| WO2007064755A2 (en) * | 2005-11-30 | 2007-06-07 | Endo Pharmaceuticals Inc. | Treatment of xerostomia with a sulfur-containing antioxidant |
| UA86441C2 (ru) * | 2007-03-30 | 2009-04-27 | Акционерное Общество Открытого Типа "Галичфарм" | (2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе |
| US20090263467A1 (en) * | 2008-04-21 | 2009-10-22 | Hemant Narahar Joshi | Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments |
| ES2579173T3 (es) * | 2009-06-15 | 2016-08-05 | Encore Health, Llc | Ésteres de colina para tratar presbicia y cataratas |
| ES2443847T3 (es) * | 2009-11-12 | 2014-02-20 | Acacia Pharma Limited | Uso de betanecol para el tratamiento de xerostomía |
| US10507245B2 (en) * | 2012-07-19 | 2019-12-17 | Luis Felipe Vejarano Restrepo | Ophthalmic formulation and method for ameliorating presbyopia |
| JP2015533174A (ja) * | 2012-10-11 | 2015-11-19 | セラヴィダ，インコーポレイテッド | ピロカルピンの医薬製剤 |
| KR101586789B1 (ko) * | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| US9427144B2 (en) * | 2014-01-03 | 2016-08-30 | Ophthalmx Llc | Methods and systems for detecting ophthalmic disease |
| US20160317606A1 (en) * | 2014-01-06 | 2016-11-03 | Stealth Bio Therapeutics Corp | Methods and compositions for preventing or treating dominant optic atrophy |
| IL265791B (en) * | 2016-10-04 | 2022-07-01 | Cellix Bio Private Ltd | Compositions and methods for the treatment of xerostomia |
| BR112020009361A2 (pt) * | 2017-11-17 | 2020-10-13 | Cellix Bio Private Limited | composto de fórmula i, composição farmacêutica para tratar um distúrbio ocular ou complicações do mesmo, método de síntese de composto, método de tratamento de um distúrbio ocular ou complicações do mesmo em um indivíduo que precisa do mesmo e uso de um composto |
| US20220096467A1 (en) * | 2019-01-12 | 2022-03-31 | Cellix Bio Provate Limited | Combination of selective alpha-adrenergic receptor agonist or an anticholinergic agent and lipoic acid and uses thereof |
-
2019
- 2019-02-05 EP EP19747106.3A patent/EP3749303A4/en not_active Withdrawn
- 2019-02-05 MX MX2020008173A patent/MX2020008173A/es unknown
- 2019-02-05 SG SG11202006492SA patent/SG11202006492SA/en unknown
- 2019-02-05 RU RU2020122659A patent/RU2020122659A/ru unknown
- 2019-02-05 WO PCT/IB2019/050901 patent/WO2019150341A1/en not_active Ceased
- 2019-02-05 BR BR112020015436-9A patent/BR112020015436A2/pt not_active Application Discontinuation
- 2019-02-05 AU AU2019214557A patent/AU2019214557A1/en not_active Abandoned
- 2019-02-05 KR KR1020207025451A patent/KR20200118128A/ko not_active Ceased
- 2019-02-05 JP JP2020542141A patent/JP2021512876A/ja active Pending
- 2019-02-05 CA CA3089894A patent/CA3089894A1/en active Pending
-
2020
- 2020-07-02 ZA ZA2020/04058A patent/ZA202004058B/en unknown
- 2020-07-28 IL IL276350A patent/IL276350A/en unknown
- 2020-08-04 US US16/985,187 patent/US20200375961A1/en not_active Abandoned
-
2022
- 2022-11-23 US US17/993,868 patent/US20230310391A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2020122659A (ru) | Комбинация антимускаринового или антихолинергического средства и липоевой кислоты и ее применения | |
| JP2004526745A5 (enExample) | ||
| JP7368354B2 (ja) | 特異的炎症収束性メディエーターの塩に関連する組成物及び方法 | |
| AU2012338362B2 (en) | Tricyclic compounds, compositions comprising them and uses thereof | |
| ES2979262T3 (es) | Composiciones que comprenden metilfenidato-profármacos, procesos de elaboración y uso de las mismas | |
| JP7524411B2 (ja) | 硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び／又は治療のための使用 | |
| AU2014209387A1 (en) | Toxic aldehyde related diseases and treatment | |
| EP3157936A1 (en) | Mineral amino-acid complexes of active agents | |
| BRPI0708071A2 (pt) | derivados de catecolamina deuterada e medicamentos compreendendo os ditos compostos | |
| BR112013020424A2 (pt) | Nitrocatecol substituído, utilizações do mesmo, combinação e composição que o compreendem | |
| RU2019113465A (ru) | Композиции и способы лечения ксеростомии | |
| CN103228618B (zh) | 新化合物及其医药用途 | |
| JP2022191331A (ja) | 炎症及び疼痛の治療のための組成物及び方法 | |
| CN111801013A (zh) | 小分子核受体调节剂的酰胺前药 | |
| CN112384214A (zh) | 作为可溶性鸟苷酸环化酶激活剂的烷氧基吡唑 | |
| WO2016020919A1 (en) | Compositions comprising tricyclic compounds, and uses thereof | |
| US20170319519A1 (en) | Combination for the treatment of conditions involving muscular pain | |
| JP2023517919A5 (enExample) | ||
| JP2020533402A5 (enExample) | ||
| JP2023518640A5 (enExample) | ||
| US9505709B2 (en) | Compositions and methods relating to ionic salts of peptides | |
| JP2025513296A5 (enExample) | ||
| CN109310669B (zh) | 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途 | |
| PT1174131E (pt) | Utilização de um agente que melhora a função dos astrocitos para o tratamento da doença de parkinson | |
| RU2019119103A (ru) | Композиции и способы лечения инфекционных заболеваний ротовой полости |